FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,006,555 | -29.3% | 201,311 | -0.4% | 0.00% | – |
| Q2 2023 | $1,423,242 | +23.4% | 202,165 | +8.6% | 0.00% | – |
| Q1 2023 | $1,153,665 | -0.3% | 186,075 | +2.6% | 0.00% | – |
| Q4 2022 | $1,157,415 | -26.7% | 181,413 | -1.5% | 0.00% | – |
| Q3 2022 | $1,580,000 | -37.9% | 184,149 | -1.5% | 0.00% | -100.0% |
| Q2 2022 | $2,543,000 | -0.9% | 186,998 | +11.0% | 0.00% | – |
| Q1 2022 | $2,566,000 | -34.2% | 168,462 | -1.2% | 0.00% | -100.0% |
| Q4 2021 | $3,899,000 | +59.9% | 170,476 | -2.6% | 0.00% | – |
| Q3 2021 | $2,439,000 | +40.3% | 175,072 | +7.5% | 0.00% | – |
| Q2 2021 | $1,738,000 | +56.6% | 162,900 | +93.2% | 0.00% | – |
| Q1 2021 | $1,110,000 | -38.1% | 84,296 | -4.7% | 0.00% | – |
| Q4 2020 | $1,792,000 | – | 88,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $16,623,000 | 5.56% |
| Flagship Pioneering Inc. | 12,674,120 | $167,045,000 | 2.68% |
| Birchview Capital, LP | 314,143 | $4,140,000 | 2.46% |
| Monashee Investment Management LLC | 530,581 | $6,993,000 | 1.08% |
| Artal Group S.A. | 1,720,720 | $22,679,000 | 0.40% |
| Octagon Capital Advisors LP | 69,132 | $911,000 | 0.34% |
| Cormorant Asset Management, LP | 1,000,000 | $13,180,000 | 0.29% |
| Alphabet Inc. | 500,901 | $6,602,000 | 0.27% |
| Casdin Capital, LLC | 216,216 | $2,850,000 | 0.08% |
| Board of Trustees of The Leland Stanford Junior University | 30,657 | $404,000 | 0.04% |